Paper41006587
Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling.
Su L and 4 others. Sci Rep, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling. Papers, record 41006587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006587
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Wnt Signaling Pathway | Major topic |
| Alcohol Dehydrogenase | Major topic |
| Humans | |
| Female | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Gene Expression Regulation, Neoplastic | |
| Cell Movement | |
| Apoptosis | |
| beta Catenin |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31548545 | Breast cancer. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31548545 | PubMed |
| 2 | 35847355 | Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer. | J Oncol | 2022 | https://conductscience.org/library/papers/35847355 | PubMed |
| 3 | 32542016 | Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. | PLoS One | 2020 | https://conductscience.org/library/papers/32542016 | PubMed |
| 4 | 15894488 | Plasma free amino acid profile in cancer patients. | Semin Cancer Biol | 2005 | https://conductscience.org/library/papers/15894488 | PubMed |
| 5 | 30524660 | Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/30524660 | PubMed |
| 6 | 27397503 | Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma. | Hum Mutat | 2016 | https://conductscience.org/library/papers/27397503 | PubMed |
| 7 | 23954227 | Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome. | Gene | 2013 | https://conductscience.org/library/papers/23954227 | PubMed |
| 8 | 34367990 | Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34367990 | PubMed |
| 9 | 35203444 | Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203444 | PubMed |
| 10 | 24374807 | EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration. | J Pathol | 2014 | https://conductscience.org/library/papers/24374807 | PubMed |
| 11 | 10592173 | KEGG: kyoto encyclopedia of genes and genomes. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592173 | PubMed |
| 12 | 36341373 | Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36341373 | PubMed |
| 13 | 39073262 | Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39073262 | PubMed |
| 14 | 36038913 | Recent advances in therapeutic strategies for triple-negative breast cancer. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36038913 | PubMed |
| 15 | 28053091 | Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28053091 | PubMed |
| 16 | 33287761 | Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma. | BMC Cancer | 2020 | https://conductscience.org/library/papers/33287761 | PubMed |
| 17 | 37056938 | Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37056938 | PubMed |
| 18 | 31585088 | Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. | Cell | 2019 | https://conductscience.org/library/papers/31585088 | PubMed |
| 19 | 20370557 | Reactive oxygen species in cancer. | Free Radic Res | 2010 | https://conductscience.org/library/papers/20370557 | PubMed |
| 20 | 26476454 | KEGG as a reference resource for gene and protein annotation. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26476454 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42445384 | A pan-cancer functional atlas of ADH1A reveals its conserved role in the tumor microenvironment and immunity. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445384 | PubMed |
| 42035094 | Overexpression of ENDOD1 inhibits proliferation, migration, and invasion of colorectal cancer. | Cell Div | 2026 | https://conductscience.org/library/papers/42035094 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41006587
GET https://conductscience.org/api/papers/v1/41006587/references?page=2